本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

再鼎醫藥

41.00
-2.0300-4.72%
盤後41.000.00000.00%18:37 EDT
成交量:102.14萬
成交額:4,201.25萬
市值:44.47億
市盈率:-16.53
高:42.00
開:41.49
低:40.73
收:43.03
資料載入中...
2020/04/29

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/23

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]